Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

01-12-2020 | Lymphoma | Case report

Nasopharyngeal B-cell lymphoma with pan-hypopituitarism and oculomotor nerve palsy: a case report and review of the literature

Authors: Maryam Zahedi, Reyhane Hizomi Arani, Maryam Tohidi, Shirin Haghighi, Masoud Mehrpour, Farzad Hadaegh

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Background

Primary nasopharyngeal lymphoma (NPL) is a very rare tumor of Waldeyer ring (WR) lymphoid tissue. It is challenging to differentiate lymphoma infiltration of pituitary from a pituitary adenoma, meningioma infiltration, and other sellar lesions to plan a suitable treatment strategy. We presented for the first time a unique case of NPL with an unusual presentation of oculomotor nerve palsy associated with pan-pituitary involvement in a diabetic patient.

Case presentation

A 64-year old diabetic woman with no previous history of malignancy presented with intermittent diplopia for about the last nine months. Severe headache, left eye ptosis and hypoglycemic episodes were added to her symptoms after a while. Further complaints include generalized weakness, loss of appetite, generalized musculoskeletal pain, and 6–7 kg weight loss within six months. Her family history was unremarkable. Physical examinations of eyes indicated left eye 3rd, 4th, and 6th nerve palsy. But, she was not anisocoric, and the pupillary reflexes were normal on both eyes. No lymphadenopathy, organomegaly and other abnormalities were found. Magnetic resonance imaging (MRI) showed a heterogeneous enhancement in the seller and suprasellar regions, enlargement of the stalk, parasellar dural enhancement and thickening of the sphenoid sinus without bone erosion. Also, both cavernous sinuses were infiltrated and both internal carotid arteries were encased by the neoplastic lesion. It suggested an infiltrative neoplastic lesion which compressed the cranial nerves. Pituitary hormone levels assessment indicated a pan-hypopituitarism. Following nasopharyngeal mucosal biopsy, the immunohistochemistry (IHC) findings revealed a low-grade non-Hodgkin’s B-cell lymphoma. Systemic workup, including cerebrospinal fluid (CSF) studies, bone marrow aspiration, chest and abdominopelvic high-resolution computed tomography (HRCT) indicated no other involvement by the lymphoma. After chemotherapy courses, central adrenal insufficiency, partial central diabetes incipidious (CDI) and central hypothyroidism have been resolved. To our best knowledge, we found 17 cases of NPL with cranial nerve palsy, 1 case of NPL with pan-hypopituitarism and no NPL case with both cranial nerve palsy and pituitary dysfunction.

Conclusions

The incidence of cranial neuropathy in patients with diabetes should not merely be attributed to diabetic neuropathy without further evaluation.
Literature
1.
go back to reference Wu R-Y, Li Y-X, Wang W-H, Jin J, Wang S-L, Liu Y-P, Song Y-W, Fang H, Ren H, Liu Q-F. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma. Am J Clin Oncol. 2014;37(1):41–6.CrossRefPubMed Wu R-Y, Li Y-X, Wang W-H, Jin J, Wang S-L, Liu Y-P, Song Y-W, Fang H, Ren H, Liu Q-F. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma. Am J Clin Oncol. 2014;37(1):41–6.CrossRefPubMed
2.
go back to reference Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, Patmore R, Jack A, Roman E. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological malignancy research network. Br J Cancer. 2015;112(9):1575–84.CrossRefPubMedPubMedCentral Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, Patmore R, Jack A, Roman E. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological malignancy research network. Br J Cancer. 2015;112(9):1575–84.CrossRefPubMedPubMedCentral
3.
go back to reference Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M, Sun L, Wei L, Li M, Liu C. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012;138(3):429–34.CrossRefPubMed Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M, Sun L, Wei L, Li M, Liu C. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012;138(3):429–34.CrossRefPubMed
4.
go back to reference Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: a review of 1269 cases. Medicine. 1961;40(1):31–84.CrossRefPubMed Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: a review of 1269 cases. Medicine. 1961;40(1):31–84.CrossRefPubMed
5.
go back to reference Hsueh C-Y, Yang C-F, Gau J-P, Kuan EC, Ho C-Y, Chiou T-J, Hsiao L-T, Lin T-A, Lan M-Y. Nasopharyngeal lymphoma: a 22-year review of 35 cases. J Clin Med. 2019;8(10):1604.CrossRefPubMedCentral Hsueh C-Y, Yang C-F, Gau J-P, Kuan EC, Ho C-Y, Chiou T-J, Hsiao L-T, Lin T-A, Lan M-Y. Nasopharyngeal lymphoma: a 22-year review of 35 cases. J Clin Med. 2019;8(10):1604.CrossRefPubMedCentral
6.
go back to reference Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894–904.CrossRefPubMedPubMedCentral Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894–904.CrossRefPubMedPubMedCentral
7.
go back to reference Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE, Thalassinos NC. Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab. 2004;89(2):574–80.CrossRefPubMed Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE, Thalassinos NC. Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab. 2004;89(2):574–80.CrossRefPubMed
8.
go back to reference Bonneville JF, Bonneville F, Cattin F. [MRI of the pituitary gland: indications and results in gynaecology and in obstetrics].Gynecol Obstet Fertil. 2005;33(3):147–53. Bonneville JF, Bonneville F, Cattin F. [MRI of the pituitary gland: indications and results in gynaecology and in obstetrics].Gynecol Obstet Fertil. 2005;33(3):147–53.
9.
go back to reference Ng S, Fomekong F, Delabar V, Jacquesson T, Enachescu C, Raverot G, Manet R, Jouanneau E. Current status and treatment modalities in metastases to the pituitary: a systematic review. J Neuro-Oncol. 2020;146(2):219–27.CrossRef Ng S, Fomekong F, Delabar V, Jacquesson T, Enachescu C, Raverot G, Manet R, Jouanneau E. Current status and treatment modalities in metastases to the pituitary: a systematic review. J Neuro-Oncol. 2020;146(2):219–27.CrossRef
10.
go back to reference Shimon I. Metastatic Spread to the Pituitary. Neuroendocrinology. 2020;110(9-10):805–8. Shimon I. Metastatic Spread to the Pituitary. Neuroendocrinology. 2020;110(9-10):805–8.
11.
go back to reference He W, Chen F, Dalm B, Kirby PA, Greenlee JD. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary. 2015;18(1):159–68.CrossRefPubMed He W, Chen F, Dalm B, Kirby PA, Greenlee JD. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary. 2015;18(1):159–68.CrossRefPubMed
12.
go back to reference Novák V, Hrabálek L, Hampl M, Hoza J, Fryšák Z, Vaverka M. Metastatic pituitary disorders. Klin Onkol. 2017;30(4):273–81.CrossRefPubMed Novák V, Hrabálek L, Hampl M, Hoza J, Fryšák Z, Vaverka M. Metastatic pituitary disorders. Klin Onkol. 2017;30(4):273–81.CrossRefPubMed
13.
go back to reference Carpinteri R, Patelli I, Casanueva F, Giustina A. Inflammatory and granulomatous expansive lesions of the pituitary. Best Pract Res Clin Endocrinol Metab. 2009;23(5):639–50.CrossRefPubMed Carpinteri R, Patelli I, Casanueva F, Giustina A. Inflammatory and granulomatous expansive lesions of the pituitary. Best Pract Res Clin Endocrinol Metab. 2009;23(5):639–50.CrossRefPubMed
14.
go back to reference Ganger A. A comprehensive review on the management of III nerve palsy. Delhi J Ophthalmol. 2016;27(2):86–91.CrossRef Ganger A. A comprehensive review on the management of III nerve palsy. Delhi J Ophthalmol. 2016;27(2):86–91.CrossRef
15.
go back to reference Brazis PW. Isolated palsies of cranial nerves III, IV, and VI. In: Seminars in neurology: 2009: Thieme Medical Publishers; 2009. p. 014–28. Brazis PW. Isolated palsies of cranial nerves III, IV, and VI. In: Seminars in neurology: 2009: Thieme Medical Publishers; 2009. p. 014–28.
16.
go back to reference Said G. Diabetic neuropathy--a review. Nat Clin Pract Neuroly. 2007;3(6):331–40. Said G. Diabetic neuropathy--a review. Nat Clin Pract Neuroly. 2007;3(6):331–40.
19.
go back to reference Sato H, Hashimoto T, Yoneda S, Hirabayashi K, Oguchi K, Higuchi K. Lymphoma as a cause of isolated oculomotor nerve palsy. J Clin Neurosci. 2011;18(9):1256–8.CrossRefPubMed Sato H, Hashimoto T, Yoneda S, Hirabayashi K, Oguchi K, Higuchi K. Lymphoma as a cause of isolated oculomotor nerve palsy. J Clin Neurosci. 2011;18(9):1256–8.CrossRefPubMed
20.
go back to reference Carroll CG, Campbell WW: Multiple cranial neuropathies. In: Seminars in neurology: 2009: © Thieme Medical Publishers; 2009. p.53–65. Carroll CG, Campbell WW: Multiple cranial neuropathies. In: Seminars in neurology: 2009: © Thieme Medical Publishers; 2009. p.53–65.
21.
go back to reference Tarabay A, Cossu G, Berhouma M, Levivier M, Daniel RT, Messerer M. Primary pituitary lymphoma: an update of the literature. J Neurooncol. 2016;130(3):383–95. Tarabay A, Cossu G, Berhouma M, Levivier M, Daniel RT, Messerer M. Primary pituitary lymphoma: an update of the literature. J Neurooncol. 2016;130(3):383–95.
22.
go back to reference Allam W, Ismaili N, Elmajjaoui S, Elgueddari BK, Ismaili M, Errihani H. Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patients. BMC Ear Nose Throat Disord. 2009;9(1):11.CrossRefPubMedPubMedCentral Allam W, Ismaili N, Elmajjaoui S, Elgueddari BK, Ismaili M, Errihani H. Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patients. BMC Ear Nose Throat Disord. 2009;9(1):11.CrossRefPubMedPubMedCentral
23.
go back to reference Lei K-K, Suen J, Hui P, Tong M, Li W, Yau S. Primary nasal and nasopharyngeal lymphomas: a comparative study of clinical presentation and treatment outcome. Clin Oncol. 1999;11(6):379–87.CrossRef Lei K-K, Suen J, Hui P, Tong M, Li W, Yau S. Primary nasal and nasopharyngeal lymphomas: a comparative study of clinical presentation and treatment outcome. Clin Oncol. 1999;11(6):379–87.CrossRef
24.
go back to reference Yuan Z, Li Y, Zhao L, Gao Y, Liu X, Gu D, Qian T, Yu Z. Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin’s lymphoma of the nasopharynx. Zhonghua Zhong Liu Za Zhi. 2004;26(7):425–9.PubMed Yuan Z, Li Y, Zhao L, Gao Y, Liu X, Gu D, Qian T, Yu Z. Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin’s lymphoma of the nasopharynx. Zhonghua Zhong Liu Za Zhi. 2004;26(7):425–9.PubMed
25.
go back to reference Urquhart A, Berg R. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Laryngoscope. 2001;111(9):1565–9.CrossRefPubMed Urquhart A, Berg R. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Laryngoscope. 2001;111(9):1565–9.CrossRefPubMed
26.
go back to reference Chin H, Quek T, Leow M. Central diabetes insipidus unmasked by corticosteroid therapy for cerebral metastases: beware the case with pituitary involvement and hypopituitarism. JR Coll Phys Edinb. 2017;47:247–9. Chin H, Quek T, Leow M. Central diabetes insipidus unmasked by corticosteroid therapy for cerebral metastases: beware the case with pituitary involvement and hypopituitarism. JR Coll Phys Edinb. 2017;47:247–9.
27.
go back to reference Foo SH, Sobah SA: Burkitt’s lymphoma presenting with hypopituitarism: a case report and review of literature. Endocrinol Diab Metab Case Rep 2014, 2014(1). Foo SH, Sobah SA: Burkitt’s lymphoma presenting with hypopituitarism: a case report and review of literature. Endocrinol Diab Metab Case Rep 2014, 2014(1).
28.
go back to reference Mohammadianpanah M, Ahmadloo N, Mozaffari MA, Mosleh-Shirazi MA, Omidvari S, Mosalaei A. Primary localized stages I and II non- Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience. Ann Hematol. 2009;88(5):441–7. Mohammadianpanah M, Ahmadloo N, Mozaffari MA, Mosleh-Shirazi MA, Omidvari S, Mosalaei A. Primary localized stages I and II non- Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience. Ann Hematol. 2009;88(5):441–7.
29.
go back to reference Da Silva RL, Fernandes T, Lopes A, Santos S, Mafra M, Rodrigues AS, de Sousa AB. B lymphoblastic lymphoma presenting as a tumor of the nasopharynx in an adult patient. Head Neck Pathol. 2010;4(4):318–23.CrossRef Da Silva RL, Fernandes T, Lopes A, Santos S, Mafra M, Rodrigues AS, de Sousa AB. B lymphoblastic lymphoma presenting as a tumor of the nasopharynx in an adult patient. Head Neck Pathol. 2010;4(4):318–23.CrossRef
30.
go back to reference Kay MC, McCrary JA. Multiple cranial nerve palsies in late metastasis of midline malignant reticulosis. Am J Ophthalmol. 1979;88(6):1087–90.CrossRefPubMed Kay MC, McCrary JA. Multiple cranial nerve palsies in late metastasis of midline malignant reticulosis. Am J Ophthalmol. 1979;88(6):1087–90.CrossRefPubMed
32.
go back to reference Riggs HE, Rupp C, Ray H, Yaskin JC. Cranial nerve syndromes associated with nasopharyngeal malignancy. AMA Arch Neurol Psychiatr. 1957;77(5):473–82.CrossRef Riggs HE, Rupp C, Ray H, Yaskin JC. Cranial nerve syndromes associated with nasopharyngeal malignancy. AMA Arch Neurol Psychiatr. 1957;77(5):473–82.CrossRef
33.
go back to reference Van der Vliet H, van Oers M, Schot L, Majoie C, van der Meer J. A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient. Ann Hematol. 2002;81(3):164–6.CrossRefPubMed Van der Vliet H, van Oers M, Schot L, Majoie C, van der Meer J. A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient. Ann Hematol. 2002;81(3):164–6.CrossRefPubMed
34.
go back to reference Ingram L, Fairclough D, Furman W, Sandlund J, Kun L, Rivera G, Pui CH. Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. Cancer. 1991;67(9):2262–8.CrossRefPubMed Ingram L, Fairclough D, Furman W, Sandlund J, Kun L, Rivera G, Pui CH. Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. Cancer. 1991;67(9):2262–8.CrossRefPubMed
35.
go back to reference Bunick EM, Hirsh LF, Rose LI. Panhypopituitarism resulting from Hodgkin’s disease of the nasopharynx. Cancer. 1978;41(3):1134–6.CrossRefPubMed Bunick EM, Hirsh LF, Rose LI. Panhypopituitarism resulting from Hodgkin’s disease of the nasopharynx. Cancer. 1978;41(3):1134–6.CrossRefPubMed
Metadata
Title
Nasopharyngeal B-cell lymphoma with pan-hypopituitarism and oculomotor nerve palsy: a case report and review of the literature
Authors
Maryam Zahedi
Reyhane Hizomi Arani
Maryam Tohidi
Shirin Haghighi
Masoud Mehrpour
Farzad Hadaegh
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00644-y

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine